This meta-analysis assessed the relationship between TTF-1 expression and EGFR mutations in NSCLC to clarify whether TTF-1 can be a potential predictive biomarker for EGFR mutation status in patients with NSLCL. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.